Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions

被引:18
|
作者
Horie, Kazunori [1 ]
Tanaka, Akiko [1 ]
Taguri, Masataka [2 ]
Inoue, Naoto [1 ]
机构
[1] Sendai Kousei Hosp, Dept Cardiovasc Med, Sendai, Miyagi, Japan
[2] Yokohama City Univ, Sch Data Sci, Yokohama, Kanagawa, Japan
关键词
balloon angioplasty; dissection; endovascular therapy; femoropopliteal segment; patency; peripheral artery disease; scoring balloon; ANGIOGRAPHIC DISSECTION PATTERNS; DRUG-COATED BALLOON; FEMORAL-ARTERY; CUTTING BALLOON; CLINICAL IMPACT; ELUTING STENT; ZILVER PTX; LONG; PREVALENCE; RESTENOSIS;
D O I
10.1177/1526602820914618
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: To investigate the efficacy of scoring balloons for immediate success of percutaneous transluminal angioplasty (PTA) in femoropopliteal lesions. Materials and Methods: Between 2013 and 2019, 398 consecutive patients with de novo femoropopliteal lesions were treated using PTA in our hospital. The procedure success rate was compared among patients undergoing PTA with vs without scoring balloons after 1:1 propensity score matching on hemodialysis, TransAtlantic Inter-Society Consensus II classification, Peripheral Arterial Calcium Scoring System (PACSS) grade, lesion length, and use of intravascular ultrasound. Propensity matching produced 84 patients (mean age 73.4 +/- 8.3; 65 men) treated with scoring balloons and 84 patients (mean age 75.6 +/- 8.7; 56 men) treated with plain balloons. Kaplan-Meier analysis investigated patency after the procedure in both groups; estimates are given with the 95% confidence interval (CI). Results: Residual stenosis <30% was achieved more often (77.4% vs 57.1%, p=0.005) and severe arterial dissection occurred less frequently (16.7% vs 29.8%, p=0.043) in the scoring balloon group vs the plain balloon group, respectively. The rate of provisional stenting was significantly lower after scoring balloon use (13.3% vs 29.8%, p=0.008). Multivariable analysis revealed that use of scoring balloons (p<0.001) and prolonged inflation time (p<0.001) were independent predictors of successful angioplasty, whereas chronic total occlusion (p=0.005) and longer lesion length (p=0.005) were predictors of an unsuccessful procedure. Among 108 patients with PACSS 0-3 lesions in the matched population, Kaplan-Meier analysis showed better primary patency at 18 months in the scoring balloon group in the intention to treat analysis [68.6% (95% CI 53.5% to 80.6%) vs 43.0% (95% CI 28.7% to 58.5%), p=0.044]. Conclusion: Scoring balloons may be effective in restoring acute lumen gain and preventing severe arterial dissection in femoropopliteal lesions. Moreover, scoring balloons might be associated with better primary patency at 18 months in PACSS 0-3 lesions.
引用
收藏
页码:481 / 491
页数:11
相关论文
共 50 条
  • [41] Impact of Percutaneous Transluminal Angioplasty for Treatment of Cerebral Vasospasm on Subarachnoid Hemorrhage Patient Outcomes
    Khatri, Rakesh
    Memon, Muhammad Zeeshan
    Zacharatos, Haralabos
    Taqui, Ather M.
    Qureshi, Mushtaq H.
    Vazquez, Gabriela
    Suri, M. Fareed K.
    Rodriguez, Gustavo J.
    Tummala, Ramachandra P.
    Ezzeddine, Mustapha A.
    Qureshi, Adnan I.
    NEUROCRITICAL CARE, 2011, 15 (01) : 28 - 33
  • [42] Impact of Hyperuricemia on 5-year Clinical Outcomes in Patients With Percutaneous Transluminal Angioplasty
    Rha, Seung-Woon
    Ahn, Woo Jin
    An, Seong Joon
    Choi, Byoung Geol
    Choi, Se Yeon
    Byun, Jae Kyeong
    Cha, Jinah
    Hyun, Sujin
    Park, Soohyung
    Kang, Dong Oh O.
    Park, Eun Jin J.
    Choi, Cheol Ung
    CIRCULATION, 2023, 148
  • [43] Percutaneous transluminal angioplasty balloons for endoscopic ultrasound-guided pancreatic duct interventions
    AbiMansour, Jad P.
    Abu Dayyeh, Barham K.
    Levy, Michael J.
    Storm, Andrew C.
    Martin, John A.
    Petersen, Bret T.
    Law, Ryan J.
    Topazian, Mark D.
    Chandrasekhara, Vinay
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2022, 14 (08): : 487 - 494
  • [44] Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
    Haraguchi, Takuya
    Tsujimoto, Masanaga
    Otake, Ryo
    Kashima, Yoshifumi
    Sato, Katsuhiko
    Fujita, Tsutomu
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2023, 29 (03): : 535 - 541
  • [45] Intragraft Pressures Predict Outcomes in Hemodialysis Patients With Graft Outflow Lesions Undergoing Percutaneous Transluminal Angioplasty
    Lai, Chi-Cheng
    Chung, Hsiao-Min
    Tsai, Han-Lin
    Mar, Guang-Yuan
    Tseng, Ching-Jiunn
    Liu, Chun-Peng
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (02) : 206 - 211
  • [46] Certificate of need, volume, and percutaneous transluminal coronary angioplasty outcomes
    Ho, V
    AMERICAN HEART JOURNAL, 2004, 147 (03) : 442 - 448
  • [47] Gender differences in outcomes from percutaneous transluminal coronary angioplasty
    Piontek, F
    Riley, E
    Frye, L
    Jones, J
    Schwab, L
    CHEST, 2003, 124 (04) : 154S - 154S
  • [48] In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement
    Goekgoel, Can
    Schumann, Steffen
    Diehm, Nicolas
    Zheng, Guoyan
    Buechler, Philippe
    JOURNAL OF ENDOVASCULAR THERAPY, 2017, 24 (01) : 27 - 34
  • [49] Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries
    Buszman, Pawel
    Debinski, Marcin
    Gruszka, Agata
    Janas, Piotr
    Krol, Marek
    Kondys, Marek
    Iwinski, Janusz
    Kazibutowska-Zaranska, Zofia
    Cierpka, Lech
    Tendera, Michal
    KARDIOLOGIA POLSKA, 2008, 66 (03) : 233 - 242
  • [50] Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients
    Maca, TH
    Ahmadi, R
    Derfler, K
    Ehringer, H
    Gschwandtner, ME
    Hörl, WH
    Katzenschlager, R
    Müller-Knespel, E
    Koppensteiner, R
    Schneidert, B
    Stümpflen, A
    Ugurluoglu, A
    Minar, E
    DIABETIC MEDICINE, 2002, 19 (04) : 300 - 306